Medicines and Poisons (Medicines) Regulation 2021
sec.154Labelling sold medicine
Start here
Get a plain-English read of sec.154
Turn the raw legal text into a practical explanation grounded in Medicines and Poisons (Medicines) Regulation 2021.
sec.154 Labelling sold medicine
This section does not apply in relation to an S2 medicine in a manufacturer’s pack. A pharmacist must not sell a medicine unless the labelling on the medicine complies with the labelling requirements for the medicine under the Poisons Standard, Appendix L and, if applicable to the medicine, Appendix K. However, if the medicine is an S3 medicine in a manufacturer’s pack, the pharmacist must instead attach a label to the medicine stating the following information— the date the medicine is sold; the name of the patient; the name of the medicine; if the medicine is mentioned in the Poisons Standard, Appendix K—the warning statement mentioned in Appendix K for the medicine. (sec.154-ssec.1) This section does not apply in relation to an S2 medicine in a manufacturer’s pack. (sec.154-ssec.2) A pharmacist must not sell a medicine unless the labelling on the medicine complies with the labelling requirements for the medicine under the Poisons Standard, Appendix L and, if applicable to the medicine, Appendix K. (sec.154-ssec.3) However, if the medicine is an S3 medicine in a manufacturer’s pack, the pharmacist must instead attach a label to the medicine stating the following information— the date the medicine is sold; the name of the patient; the name of the medicine; if the medicine is mentioned in the Poisons Standard, Appendix K—the warning statement mentioned in Appendix K for the medicine.
- (a) the date the medicine is sold;
- (b) the name of the patient;
- (c) the name of the medicine;
- (d) if the medicine is mentioned in the Poisons Standard, Appendix K—the warning statement mentioned in Appendix K for the medicine.